Characterization of renal damage in Wilson's disease—Detailed analysis of 20 Chinese cases

{"title":"Characterization of renal damage in Wilson's disease—Detailed analysis of 20 Chinese cases","authors":"","doi":"10.1016/j.medcle.2024.02.019","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Copper metabolism disorder disease is thought to contribute to renal symptoms in Wilson's disease (WD). Nonetheless, there remains limited knowledge regarding the precise characteristics of renal damage in individuals with Wilson's disease, encompassing clinical presentations, biochemical indicators, imaging findings, and renal histopathological alterations.</div></div><div><h3>Methods</h3><div>In this study, 20 patients diagnosed with Wilson's disease and renal involvement were enrolled in our hospital. These patients met the validated European criteria for Wilson's disease, and those with primary kidney disease or secondary renal damage caused by other underlying conditions were excluded.</div><div>The baseline data of patients were collected. Various biochemical and hematological parameters were monitored. Biochemical examinations were measured using an automatic biochemistry analyzer, blood routines were tested by flow cytometry analysis, 24-h urine copper was tested by atomic absorption spectrophotometer. Besides, CER was measured by turbidimetric immunoassay with a Hitachi 7020 automatic biochemical analyzer (the intraplate and interplate coefficients of variation were 2.7% and 5.13% respectively). Copper oxidase was tested by colorimetric method using p-phenylenediamine hydrochloride (the intraplate and interplate coefficients of variation were both &lt;10%). Diagnostic criteria for Wilson's disease and kidney damage were established based on the European Association for the Study of the Liver (EASL) and CKD Epidemiology Collaboration guidelines, respectively. Statistical analysis was carried out using <em>t</em>-tests and <em>χ</em><sup>2</sup> tests in SPSS 22.0 software. Significant differences were considered when <em>P</em> <!-->&lt;<!--> <!-->0.05.</div></div><div><h3>Results</h3><div>In those patients with Wilson's disease-related renal damage, edema, gross hematuria, oliguria, and lumbar pain were present in most patients. Microscopic haematuria and proteinuria were also observed in 19 patients. Compared to patients without renal involvement, those with renal complications exhibited a significant increase in white blood cell (WBC) and neutrophil counts (<em>P</em> <!-->&lt;<!--> <!-->0.05). Additionally, patients with renal damage showed a noteworthy rise in both diastolic and systolic blood pressure, along with a significant reduction in hemoglobin levels (<em>P</em> <!-->&lt;<!--> <!-->0.05). Color Doppler ultrasound results revealed diffuse lesions in both kidneys in 12 patients, renal cysts were identified in 5 patients, and 2 patients exhibited abnormal renal blood flow signals. Meanwhile, varying degrees of IgA, IgM, IgG-based immunoglobulins, complement C3 and C1q deposition in the glomerular mesangial area were detected by immunofluorescence. Furthermore, renal puncture biopsy results revealed a spectrum of findings, including minimal change nephrosis in 1 case, IgA nephropathy in 3 cases, atypical membranous proliferative nephropathy in 2 cases, and focal segmental glomerulosclerosis in 1 case.</div></div><div><h3>Conclusion</h3><div>This study comprehensively elucidates the distinct attributes of renal damage related to Wilson's disease, while also speculating that renal dysfunction in Wilson's disease could be linked to immune complex deposition. Depending on the underlying pathogenesis, kidney injury associated with Wilson's disease can be classified as primary or secondary. To slow down the progression of renal impairment, it is essential to undergo a renal biopsy pathological examination as early as possible to clarify the type of impairment and take the appropriate treatment.</div></div>","PeriodicalId":74154,"journal":{"name":"Medicina clinica (English ed.)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina clinica (English ed.)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2387020624004182","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

Copper metabolism disorder disease is thought to contribute to renal symptoms in Wilson's disease (WD). Nonetheless, there remains limited knowledge regarding the precise characteristics of renal damage in individuals with Wilson's disease, encompassing clinical presentations, biochemical indicators, imaging findings, and renal histopathological alterations.

Methods

In this study, 20 patients diagnosed with Wilson's disease and renal involvement were enrolled in our hospital. These patients met the validated European criteria for Wilson's disease, and those with primary kidney disease or secondary renal damage caused by other underlying conditions were excluded.
The baseline data of patients were collected. Various biochemical and hematological parameters were monitored. Biochemical examinations were measured using an automatic biochemistry analyzer, blood routines were tested by flow cytometry analysis, 24-h urine copper was tested by atomic absorption spectrophotometer. Besides, CER was measured by turbidimetric immunoassay with a Hitachi 7020 automatic biochemical analyzer (the intraplate and interplate coefficients of variation were 2.7% and 5.13% respectively). Copper oxidase was tested by colorimetric method using p-phenylenediamine hydrochloride (the intraplate and interplate coefficients of variation were both <10%). Diagnostic criteria for Wilson's disease and kidney damage were established based on the European Association for the Study of the Liver (EASL) and CKD Epidemiology Collaboration guidelines, respectively. Statistical analysis was carried out using t-tests and χ2 tests in SPSS 22.0 software. Significant differences were considered when P < 0.05.

Results

In those patients with Wilson's disease-related renal damage, edema, gross hematuria, oliguria, and lumbar pain were present in most patients. Microscopic haematuria and proteinuria were also observed in 19 patients. Compared to patients without renal involvement, those with renal complications exhibited a significant increase in white blood cell (WBC) and neutrophil counts (P < 0.05). Additionally, patients with renal damage showed a noteworthy rise in both diastolic and systolic blood pressure, along with a significant reduction in hemoglobin levels (P < 0.05). Color Doppler ultrasound results revealed diffuse lesions in both kidneys in 12 patients, renal cysts were identified in 5 patients, and 2 patients exhibited abnormal renal blood flow signals. Meanwhile, varying degrees of IgA, IgM, IgG-based immunoglobulins, complement C3 and C1q deposition in the glomerular mesangial area were detected by immunofluorescence. Furthermore, renal puncture biopsy results revealed a spectrum of findings, including minimal change nephrosis in 1 case, IgA nephropathy in 3 cases, atypical membranous proliferative nephropathy in 2 cases, and focal segmental glomerulosclerosis in 1 case.

Conclusion

This study comprehensively elucidates the distinct attributes of renal damage related to Wilson's disease, while also speculating that renal dysfunction in Wilson's disease could be linked to immune complex deposition. Depending on the underlying pathogenesis, kidney injury associated with Wilson's disease can be classified as primary or secondary. To slow down the progression of renal impairment, it is essential to undergo a renal biopsy pathological examination as early as possible to clarify the type of impairment and take the appropriate treatment.
威尔逊氏病肾损害的特征--20 例中国病例的详细分析
目的铜代谢紊乱疾病被认为是导致威尔逊氏病(WD)肾脏症状的原因之一。然而,人们对威尔逊氏病患者肾脏损害的确切特征,包括临床表现、生化指标、影像学检查结果和肾脏组织病理学改变的了解仍然有限。这些患者均符合欧洲威尔逊氏病的有效标准,并排除了原发性肾脏疾病或由其他基础疾病引起的继发性肾损害的患者。收集了患者的基线数据,监测了各种生化指标和血液指标。生化检查采用自动生化分析仪,血液常规采用流式细胞术分析,24 小时尿铜采用原子吸收分光光度计。此外,还使用日立 7020 自动生化分析仪通过比浊免疫测定法测定了 CER(板内变异系数为 2.7%,板间变异系数为 5.13%)。铜氧化酶采用对苯二胺盐酸盐比色法检测(板内和板间变异系数均为 10%)。威尔逊氏病和肾损伤的诊断标准分别根据欧洲肝脏研究协会(EASL)和 CKD 流行病学协作组指南制定。统计分析采用 SPSS 22.0 软件中的 t 检验和 χ2 检验。结果在威尔逊氏病相关肾损害患者中,大多数患者出现水肿、毛细血尿、少尿和腰痛。19名患者还出现了镜下血尿和蛋白尿。与没有肾脏受累的患者相比,肾脏并发症患者的白细胞(WBC)和中性粒细胞计数显著增加(P < 0.05)。此外,肾脏受损患者的舒张压和收缩压均明显升高,血红蛋白水平显著下降(P < 0.05)。彩色多普勒超声结果显示,12 名患者的双肾出现弥漫性病变,5 名患者发现肾囊肿,2 名患者出现肾血流信号异常。同时,免疫荧光检测到肾小球系膜区有不同程度的 IgA、IgM、IgG 类免疫球蛋白、补体 C3 和 C1q 沉积。此外,肾穿刺活检结果显示了一系列结果,包括 1 例微小病变肾病、3 例 IgA 肾病、2 例非典型膜性增生性肾病和 1 例局灶节段性肾小球硬化。根据潜在的发病机制,与威尔逊氏病相关的肾损伤可分为原发性和继发性两种。为了延缓肾功能损害的进展,必须尽早进行肾活检病理检查,以明确损害类型并采取适当的治疗措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信